Dr John Lucas is stepping down in order to pursue other business interests.
Research studies of LED spectra and intensity have shown a positive impact on floral cannabis yield.
Toxicological studies suggest the average daily intake of isolated CBD should be well below current guidelines.
Ramm Pharma said the acquisition will give it an additional foothold into the European market.
The company said the approval has bolstered its position in Europe.
Gedeon’s cannabis and commercial expertise will further Canopy Growth’s strategy for North American cannabis leadership, the company said.
“We are honoured to be given the opportunity to work hand-in-hand with the Misak people,” said Luis Merchan, Flora’s Chairman and CEO.
Miles Worne will be Curaleaf International’s first president.
The company said it identified potential savings in moving its domestic and international manufacturing to its Canadian facility.
The total addressable market for the drug is expected to be nearly $1.7 billion by 2028.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
